Genedata Expands Its Research Informatics Partnership with Bayer Schering Pharma

Basel, Switzerland, November 3, 2008

Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the expansion of its 10 year research informatics partnership with Bayer HealthCare to include all of Bayer Schering Pharma (BSP) drug discovery research sites. Genedata will provide its enterprise software platforms for research data integration and analysis across the Bayer Schering Pharma sites globally to help consolidate and harmonize the drug discovery process.

“Our scalable and open enterprise software platforms are perfectly suited to integrating a variety of drug discovery related data across multiple locations, functions and projects,” said Dr. Othmar Pfannes, CEO of Genedata. “We are pleased to be able to expand our collaboration by providing research informatics systems that ease the information consolidation process of disparate datasets and systems.”

The Genedata collaboration with Bayer Schering Pharma includes the provision and the tailoring of the Genedata Expressionist® and Phylosopher® platforms to support BSP’s research processes. In addition, Genedata will provide professional services to support integration and to provide interfaces to existing research logistics infrastructure including laboratory technologies and related IT systems.

Genedata Phylosopher® is used for consolidating portfolios of therapeutic targets and for managing the increasing complexity of biological target information. By integrating targets with proprietary compound information, patent information, disease pathways and information on experimental evidences indicating impact on relevant medical indications, Phylosopher represents the central target database that connects the different research groups on a global scale within BSP.

Genedata Expressionist® is used for high throughput processing and quality control of raw gene expression data as well as for statistical analysis to identify differentially expressed genes for target candidate identification, compound profiling, and mode of action studies. Genedata Phylosopher is subsequently used to evaluate and prioritize target candidates.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US.

Allison Kurz
Marketing & Communications
Phone: +41 61 511 8459

Jackie Thrasivoulos
Public Relations
Phone: +1 508 881 3109


The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.